Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 97,800 | 96,042 | 88,183 | 91,140 | 83,841 |
| Cost of Goods | 4,263 | 7,165 | 5,028 | 4,949 | 6,684 |
| Gross Profit | 93,537 | 88,877 | 83,155 | 86,191 | 77,157 |
| Operating Expenses | 52,426 | 49,735 | 47,006 | 45,799 | 55,369 |
| Operating Income | 41,374 | 39,307 | 36,177 | 41,341 | 22,472 |
| Other Income | 6,593 | 7,468 | 7,420 | 7,269 | 7,297 |
| Pre-tax Income | 47,967 | 46,775 | 43,597 | 48,610 | 29,769 |
| Income Tax | -31,398 | 8,442 | 7,864 | 3,131 | 2,589 |
| Net Income Continuous | 79,365 | 38,333 | 35,733 | 45,479 | 27,180 |
| Net Income | $79,365 | $38,333 | $35,733 | $45,479 | $27,180 |
| EPS Basic Total Ops | 2.74 | 1.33 | 1.24 | 1.60 | 0.95 |
| EPS Basic Continuous Ops | 2.74 | 1.33 | 1.24 | 1.59 | 0.95 |
| EPS Diluted Total Ops | 2.66 | 1.29 | 1.20 | 1.53 | 0.91 |
| EPS Diluted Continuous Ops | 2.66 | 1.29 | 1.20 | 1.53 | 0.91 |
| EPS Diluted Before Non-Recurring Items | 2.66 | 1.29 | 1.20 | 1.52 | 0.91 |
| EBITDA(a) | $42,986 | $40,850 | $37,811 | $42,896 | $24,001 |